Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis
- 1 December 1996
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 36 (5) , 1251-1261
- https://doi.org/10.1016/s0360-3016(96)00376-8
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- High-resolution 1H-magnetic resonance spectroscopy of pediatric posterior fossa tumors in vitroJournal of Neurosurgery, 1994
- Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomasCancer, 1994
- 1H MRS of high grade astrocytomas: Mobile lipid accumulation in necrotic tissueNMR in Biomedicine, 1994
- Proton Magnetic Resonance Spectroscopy of Pediatric Brain TumorsNeurosurgery, 1992
- Proton MR Spectroscopy of Experimental Radiation-Induced White Matter InjuryJournal of Computer Assisted Tomography, 1992
- Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor gradingNMR in Biomedicine, 1990
- 1H image‐guided localized 31P MR spectroscopy of human brain: Quantitative analysis of 31P MR spectra measured on volunteers and on intracranial tumor patientsMagnetic Resonance in Medicine, 1989
- Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studiesAmerican Journal of Roentgenology, 1988
- Delayed radiation necrosis of brain evaluated positron emission tomography.The Tohoku Journal of Experimental Medicine, 1988
- DIVERSITY OF METABOLIC PATTERNS IN HUMAN BRAIN TUMORS—I. HIGH ENERGY PHOSPHATE COMPOUNDS AND BASIC COMPOSITION1Journal of Neurochemistry, 1977